Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-12

Clinical Trial Update: Effectiveness and Safety of Artemether + Lumefantrine and Dihydroartemisinin + Piperaquine for Treating Malaria [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the effectiveness and safety of two artemisinin-based combination therapies for malaria has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Artemether-lumefantrine (artemether and lumefantrine)
  • Dihydroartemisinin-piperaquine (dihydroartemisinin-piperaquine)

Snippet

Sponsor: Bandim Health Project | Conditions: Malaria, Effectiveness | Phase 4 | Status: COMPLETED